Sugi Predict

Sugi Predict / Compounds / SCHEMBL1471876

SCHEMBL1471876

SCHEMBL1471876

CC(C)(C)c1cc2cc(NS(=O)(=O)c3cc(Cl)c(Oc4ccc([N+](=O)[O-])cc4Cl)c(Cl)c3)ccc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.45
▸ THRA P10827 3/20 0.43
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ GAA P10253 2/20 0.42
▸ PKM P14618 1/20 0.42
▸ MAPT P10636 5/20 0.42
▸ HTT P42858 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.41
▸ PPARG P37231 1/20 0.39
▸ LMNA P02545 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ THRB P10828 1/20 0.39
▸ PLA2G7 Q13093 1/20 0.39
▸ OGT O15294 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ LGALS8 O00214 1/20 0.38
▸ LGALS3 P17931 1/20 0.38
▸ TBXA2R P21731 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1472218 0.90 CYP2C9 (0.47) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1472293 0.85 CYP2C9 (0.46) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1471467 0.81 ESR1 (0.54) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1471229 0.81 CYP2C9 (0.53) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1474475 0.80 ALDH1A1 (0.55) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1472083 0.80 THRA (0.54) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1471930 0.80 MEN1 (0.54) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1472306 0.80 LMNA (0.54) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1472290 0.80 ALDH1A1 (0.59) CYP2C9THRAMEN1KMT2AGAA
SCHEMBL1472242 0.79 THRA (0.58) CYP2C9THRAMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915293-B2 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases RIGEL PHARMACEUTICALS, INC. (US) 2011-03-29 — — US disclosed
US-7915293-B2 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases RIGEL PHARMACEUTICALS, INC. (US) 2011-03-29 — — US disclosed
US-7915293-B2 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases RIGEL PHARMACEUTICALS, INC. (US) 2011-03-29 — — US disclosed
US-20050009871-A1 Ubiquitin ligase inhibitors RIGEL PHARMACEUTICALS, INC. 2005-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009871-A1 Ubiquitin ligase inhibitors NEDD4, STUB1, UBE3A CYP2C9 3737/4885THRA 4803/4885MEN1 3441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.